T, C., II, W. R., AM, C., & P, B. (2006). Medicare's coverage of colorectal cancer drugs: A case study in evidence development and policy: Medicare's new evidence-based coverage policy could either expand or restrict beneficiaries' access to new technologies. Health Affairs, 25(5), 1231. https://doi.org/10.1377/hlthaff.25.5.1231
Chicago Style (17th ed.) CitationT, Carino, Williams RD II, Colbert AM, and Bridger P. "Medicare's Coverage of Colorectal Cancer Drugs: A Case Study in Evidence Development and Policy: Medicare's New Evidence-based Coverage Policy Could Either Expand or Restrict Beneficiaries' Access to New Technologies." Health Affairs 25, no. 5 (2006): 1231. https://doi.org/10.1377/hlthaff.25.5.1231.
MLA (9th ed.) CitationT, Carino, et al. "Medicare's Coverage of Colorectal Cancer Drugs: A Case Study in Evidence Development and Policy: Medicare's New Evidence-based Coverage Policy Could Either Expand or Restrict Beneficiaries' Access to New Technologies." Health Affairs, vol. 25, no. 5, 2006, p. 1231, https://doi.org/10.1377/hlthaff.25.5.1231.
